Cannara Biotech Inc.
LOVFF
$0.9125
$0.00610.67%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.80M | 4.66M | 3.94M | 4.61M | 6.72M |
| Total Depreciation and Amortization | 4.61M | 4.67M | 4.37M | 4.20M | 3.99M |
| Total Amortization of Deferred Charges | 172.60K | 148.40K | 326.80K | 326.80K | 193.30K |
| Total Other Non-Cash Items | 543.20K | 207.00K | 2.13M | 2.53M | -232.60K |
| Change in Net Operating Assets | 1.35M | -1.88M | -3.11M | -5.31M | -5.78M |
| Cash from Operations | 11.48M | 7.81M | 7.65M | 6.35M | 4.89M |
| Capital Expenditure | -4.34M | -5.49M | -6.46M | -6.10M | -6.52M |
| Sale of Property, Plant, and Equipment | 1.55M | 1.55M | 1.63M | 90.30K | 131.40K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 123.70K | 120.70K | 122.50K | 117.20K | 136.90K |
| Cash from Investing | -2.67M | -3.81M | -4.71M | -5.89M | -6.26M |
| Total Debt Issued | 3.70M | 5.70M | 7.20M | 6.50M | 5.50M |
| Total Debt Repaid | -4.74M | -4.67M | -4.61M | -2.19M | -2.20M |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -4.30K | -277.10K | -480.50K | -623.10K | -647.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.38M | -3.85M | -4.63M | -5.27M | -4.88M |
| Cash from Financing | -3.25M | -2.27M | -1.88M | -1.19M | -1.66M |
| Foreign Exchange rate Adjustments | -- | -- | 0.00 | 500.00 | -11.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.57M | 1.73M | 1.07M | -730.00K | -3.04M |